593
Views
12
CrossRef citations to date
0
Altmetric
Letter to the Editor

Uveitis and Papillitis in the Setting of Dabrafenib and Trametinib Therapy for Metastatic Melanoma: A Case Report

, MBBS, , MBBS, FRACP, , MBBS, FRACP, PhD & , MBBCh,FRACS FRANZCO
Pages 628-631 | Received 26 Feb 2016, Accepted 06 Oct 2016, Published online: 28 Nov 2016

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (5)

Ryan T. Yanagihara, Elysse S. Tom, Gerami D. Seitzman & Steven S. Saraf. (2022) A Case of Bilateral Multifocal Choroiditis Associated with BRAF/MEK Inhibitor Use for Metastatic Cutaneous Melanoma. Ocular Immunology and Inflammation 30:7-8, pages 2005-2009.
Read now
Andrew M Philip, Stephen D Anesi, C Stephen Foster & Peter Chang. (2022) Ocular Inflammatory Complications of Treatment for Metastatic Melanoma. Ocular Immunology and Inflammation 0:0, pages 1-5.
Read now
Ruby A. Parikh, Benjamin C. Chaon & Meghan K. Berkenstock. (2021) Ocular Complications of Checkpoint Inhibitors and Immunotherapeutic Agents: A Case Series. Ocular Immunology and Inflammation 29:7-8, pages 1585-1590.
Read now
Nora Woltsche, Michael Andreas Kruger, Martin Weger, Ingrid Hildegard Wolf & Gerald Seidel. (2021) Intravitreal Steroid Treatment for Uveitis Associated with Dabrafenib and Trametinib for Metastatic Cutaneous Melanoma. Ocular Immunology and Inflammation 29:5, pages 845-847.
Read now
Marcos Mozo Cuadrado, Laura Tabuenca Del Barrio & Esther Compains Silva. (2021) Bilateral Drug-Induced Uveitis and Epiretinal Membrane during the Treatment of a Metastatic Cutaneous Melanoma. Ocular Immunology and Inflammation 29:3, pages 543-545.
Read now

Articles from other publishers (7)

Dongchen Li, Li Yang, Feng Bai, Shun Zeng & Xiaoli Liu. (2022) Clinical Manifestations, Diagnosis, Treatment and Prognosis of Uveitis Induced by Anticancer Drugs: A Review of Literature. Brain Sciences 12:9, pages 1168.
Crossref
Rui Zhang, Seenu M. Hariprasad, George Sanchez & Dimosthenis Mantopoulos. (2021) Friends or Foes? An Update on Retinal Toxicities of Systemic Medications. Ophthalmic Surgery, Lasers and Imaging Retina 52:6, pages 302-306.
Crossref
Blake H. Fortes, Prashant D. Tailor & Lauren A. Dalvin. (2021) Ocular Toxicity of Targeted Anticancer Agents. Drugs 81:7, pages 771-823.
Crossref
S. Trad, C. Bonnet & D. Monnet. (2018) Uvéite médicamenteuse et effets indésirables des médicaments en ophtalmologie. La Revue de Médecine Interne 39:9, pages 699-710.
Crossref
T. Rueda-Rueda, J.L. Sánchez-Vicente, A. Moruno-Rodríguez, F.E. Molina-Socola, A.C. Martínez-Borrego & F. López-Herrero. (2018) Uveitis and serous retinal detachment secondary to systemic dabrafenib and trametinib. Archivos de la Sociedad Española de Oftalmología (English Edition) 93:9, pages 458-462.
Crossref
T. Rueda-Rueda, J.L. Sánchez-Vicente, A. Moruno-Rodríguez, F.E. Molina-Socola, A.C. Martínez-Borrego & F. López-Herrero. (2018) Uveítis y desprendimiento seroso de retina secundarios al tratamiento sistémico con dabrafenib y trametinib. Archivos de la Sociedad Española de Oftalmología 93:9, pages 458-462.
Crossref
. (2018) Dabrafenib/trametinib. Reactions Weekly 1706:1, pages 153-153.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.